X4 Pharmaceuticals
XFOR
XFOR
56 hedge funds and large institutions have $53.6M invested in X4 Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $60.1M → $53.6M (-$6.54M)
68% less call options, than puts
Call options by funds: $49K | Put options by funds: $151K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
56
Holding in Top 10
–
Calls
$49K
Puts
$151K
Top Buyers
| 1 | +$3.95M | |
| 2 | +$665K | |
| 3 | +$567K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$453K |
| 5 |
JPMorgan Chase & Co
New York
|
+$441K |
Top Sellers
| 1 | -$2.37M | |
| 2 | -$1.81M | |
| 3 | -$1.34M | |
| 4 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$1.09M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$806K |